Rebound COVID-19 after Paxlovid in 2 related family members

On May 24, 2022, the CDC issued a healthcare advisory after reports of COVID-19 symptoms returning (COVID-19 rebound) in certain patients two to eight days after treatment with Paxlovid (Ritonavir-Boosted Nirmatrevir). We describe two patients who experienced a rebound of COVID-19 after receiving Pa...

Full description

Saved in:
Bibliographic Details
Main Authors: Periyasamy, Petrick, Li Fen, Tan, Kori, Najma, Zainulabid, Ummu Afeera
Format: Article
Language:English
English
English
Published: Elsevier 2023
Subjects:
Online Access:http://irep.iium.edu.my/105320/7/105320_Rebound%20COVID-19.pdf
http://irep.iium.edu.my/105320/19/105320_Rebound%20of%20Covid-19%20after%20Paxlovid%20in%202%20related%20Family%20Members_WOS.pdf
http://irep.iium.edu.my/105320/13/105320_Rebound%20Covid-19%20After%20Paxlovid%20in%202%20Related%20Family%20Members_WOS.pdf
http://irep.iium.edu.my/105320/
https://www.sciencedirect.com/science/article/pii/S1201971223004472
https://doi.org/10.1016/j.ijid.2023.04.318
Tags: Add Tag
No Tags, Be the first to tag this record!